<DOC>
	<DOCNO>NCT01298219</DOCNO>
	<brief_summary>The primary purpose study evaluate efficacy safety lubiprostone administration subject OBD .</brief_summary>
	<brief_title>Opioid-induced Bowel Dysfunction Pivotal Assessment Lubiprostone ( OPAL )</brief_title>
	<detailed_description />
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Lubiprostone</mesh_term>
	<criteria>Consistent treatment chronic , noncancerrelated pain oral , transdermal , intravenous , subcutaneous opioid ( full agonist ) methadone least 30 day prior screen , continue opioid therapy throughout study . Diagnosis opioidinduced bowel dysfunction ( OBD ) confirm screening period . If patient history chronic constipation ( &gt; 90days ) , condition must exacerbate initiation opioid treatment . Use prescribe OTC medication affect gastrointestinal motility ( opioid therapy ) must discontinue screen visit completion study . If treat clinical depression SSRIs , SNRIs , MAO inhibitor , treatment must stable dose least 30 day prior screen likely change study . Patient must discontinue use laxatives stool softener ( exception approve rescue medication ) study . Treatment opioid therapy cancerrelated pain , abdominal pain , scleroderma , and/or management drug addiction . Patient current evidence , treat , cancer within past 5 year ( exception localize basal cell , squamous cell skin cancer , situ cancer resect ) . Changes opioid treatment , route administration dose adjustment ( increase decrease +/30 % morphine equivalent daily dose [ MEDD ] opioid treatment ) within 30 day screen , likelihood opioid discontinuation course study . Gastrointestinal abdominal surgical procedure within 90 day prior screen bowel resection time . Nonambulatory patient unable eat/drink , take oral medication , hold oral medication due vomit . Female patient childbearing potential unable/unwilling use protocolspecified method ( ) birth control and/or pregnant , nursing , plan become pregnant nurse study . Prior use Amitiza , lubiprostone , SPI0211 , RU0211 . Patients receive methadone , methadone HCl , congener methadone either alone part opioid regimen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>